ALL - 1736
The Efficacy and Safety of Single-Product Bispecific CD19/CD22 Chimeric Antigen Receptor T-Cell Therapy in Children, Adolescents, and Young Adults With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis
Faisal Alharbi
Poster Presenter: Faisal Alharbi